480 related articles for article (PubMed ID: 18430585)
1. Recombinant human epidermal growth factor inclusion body solubilization and refolding at large scale using expanded-bed adsorption chromatography from Escherichia coli.
Sharma K; Babu PV; Sasidhar P; Srinivas VK; Mohan VK; Krishna E
Protein Expr Purif; 2008 Jul; 60(1):7-14. PubMed ID: 18430585
[TBL] [Abstract][Full Text] [Related]
2. Renaturation, purification and characterization of streptokinase expressed as inclusion body in recombinant E. coli.
Cherish Babu PV; Srinivas VK; Krishna Mohan V; Krishna E
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(2):218-26. PubMed ID: 17981102
[TBL] [Abstract][Full Text] [Related]
3. Purification of soluble human epidermal growth factor (hEGF) from recombinant Escherichia coli culture broth by using expanded-bed adsorption chromatography.
Lee YS; Suh CW; Park SK; Lee EK
Biotechnol Appl Biochem; 2003 Aug; 38(Pt 1):9-13. PubMed ID: 12583815
[TBL] [Abstract][Full Text] [Related]
4. Refolding and purification of rhNTA protein by chromatography.
Fan X; Xu D; Lu B; Xia J; Wei D
Biomed Chromatogr; 2009 Mar; 23(3):257-66. PubMed ID: 19101913
[TBL] [Abstract][Full Text] [Related]
5. Refolding and purification of Zymomonas mobilis levansucrase produced as inclusion bodies in fed-batch culture of recombinant Escherichia coli.
Sunitha K; Chung BH; Jang KH; Song KB; Kim CH; Rhee SK
Protein Expr Purif; 2000 Apr; 18(3):388-93. PubMed ID: 10733894
[TBL] [Abstract][Full Text] [Related]
6. Refolding and purification of recombinant human VEGF-121 expressed as inclusion bodies in Escherichia coli.
Hu ZM; Ma L; Zhou MQ; Gao JM; Wang XN
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1083-6. PubMed ID: 16939889
[TBL] [Abstract][Full Text] [Related]
7. High-yield expression of human vascular endothelial growth factor VEGF(165) in Escherichia coli and purification for therapeutic applications.
Pizarro SA; Gunson J; Field MJ; Dinges R; Khoo S; Dalal M; Lee M; Kaleas KA; Moiseff K; Garnick S; Reilly DE; Laird MW; Schmelzer CH
Protein Expr Purif; 2010 Aug; 72(2):184-93. PubMed ID: 20302942
[TBL] [Abstract][Full Text] [Related]
8. Refolding and purification of recombinant human PDE7A expressed in Escherichia coli as inclusion bodies.
Richter W; Hermsdorf T; Kronbach T; Dettmer D
Protein Expr Purif; 2002 Jun; 25(1):138-48. PubMed ID: 12071709
[TBL] [Abstract][Full Text] [Related]
9. Expanded bed adsorption for recovery of renatured human recombinant interleukin 8 from Escherichia coli inclusion bodies.
Barnfield Frej AK
Bioseparation; 1996; 6(5):265-71. PubMed ID: 9210348
[TBL] [Abstract][Full Text] [Related]
10. High throughput purification of recombinant human growth hormone using radial flow chromatography.
Singh SM; Sharma A; Panda AK
Protein Expr Purif; 2009 Nov; 68(1):54-9. PubMed ID: 19500673
[TBL] [Abstract][Full Text] [Related]
11. Purification and on-column refolding of EGFP overexpressed as inclusion bodies in Escherichia coli with expanded bed anion exchange chromatography.
Cabanne C; Noubhani AM; Hocquellet A; Dole F; Dieryck W; Santarelli X
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Apr; 818(1):23-7. PubMed ID: 15722040
[TBL] [Abstract][Full Text] [Related]
12. Optimized procedure for renaturation of recombinant human bone morphogenetic protein-2 at high protein concentration.
Vallejo LF; Rinas U
Biotechnol Bioeng; 2004 Mar; 85(6):601-9. PubMed ID: 14966801
[TBL] [Abstract][Full Text] [Related]
13. On-column refolding of recombinant human interferon-gamma inclusion bodies by expanded bed adsorption chromatography.
Jin T; Guan YX; Yao SJ; Lin DQ; Cho MG
Biotechnol Bioeng; 2006 Mar; 93(4):755-60. PubMed ID: 16261630
[TBL] [Abstract][Full Text] [Related]
14. Purification and renaturation of recombinant human lymphotoxin (tumour necrosis factor beta) expressed in Escherichia coli as inclusion bodies.
Jin H; Uddin MS; Huang YL; Teo WK
J Chem Technol Biotechnol; 1994 Jan; 59(1):67-72. PubMed ID: 7764497
[TBL] [Abstract][Full Text] [Related]
15. [Using process of refolding the protein to obtain recombinant human interleukin-1 receptor antagonist].
Li S; Deng X; Zhao H; Huang X; Yu T; Cheng Y; Dan G
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Oct; 24(5):1128-32. PubMed ID: 18027711
[TBL] [Abstract][Full Text] [Related]
16. A simplified bioprocess for human alpha-fetoprotein production from inclusion bodies.
Leong SS; Middelberg AP
Biotechnol Bioeng; 2007 May; 97(1):99-117. PubMed ID: 17115449
[TBL] [Abstract][Full Text] [Related]
17. Renaturation of recombinant human neurotrophin-3 from inclusion bodies using a suppressor agent of aggregation.
Suenaga M; Ohmae H; Tsuji S; Itoh T; Nishimura O
Biotechnol Appl Biochem; 1998 Oct; 28 ( Pt 2)():119-24. PubMed ID: 9756741
[TBL] [Abstract][Full Text] [Related]
18. Expression, renaturation and simultaneous purification of recombinant human stem cell factor in Escherichia coli.
Lili W; Chaozhan W; Xindu G
Biotechnol Lett; 2006 Jul; 28(13):993-7. PubMed ID: 16786266
[TBL] [Abstract][Full Text] [Related]
19. On-column refolding and purification of recombinant human interleukin-1 receptor antagonist (rHuIL-1ra) expressed as inclusion body in Escherichia coli.
Tan H; Dan G; Gong H; Cao L
Biotechnol Lett; 2005 Aug; 27(16):1177-82. PubMed ID: 16158260
[TBL] [Abstract][Full Text] [Related]
20. Bacterial fermentation of recombinant major wasp allergen Antigen 5 using oxygen limiting growth conditions improves yield and quality of inclusion bodies.
Kischnick S; Weber B; Verdino P; Keller W; Sanders EA; Anspach FB; Fiebig H; Cromwell O; Suck R
Protein Expr Purif; 2006 Jun; 47(2):621-8. PubMed ID: 16495080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
